UniSuper Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
UniSuper Management's BMY Position: Q2 2026 in Review
UniSuper Management increased its Bristol-Myers Squibb (BMY) stake by 42% in Q2 2026, buying an estimated $3.82M and bringing the position to 224,641 shares worth $12.9M. The position accounts for 0.07% of the portfolio, ranked #167.
UniSuper Management first reported a position in BMY in Q2 2023 and has held it in 13 quarters since. The position peaked at $13.2M in Q2 2023. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- UniSuper Management held 224,641 shares of Bristol-Myers Squibb worth $12.9M as of Q2 2026.
- UniSuper Management bought 66,472 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.82M.
- Bristol-Myers Squibb made up 0.07% of UniSuper Management's portfolio in Q2 2026, its #167 holding.
- UniSuper Management first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 13 quarters since.
- UniSuper Management's Bristol-Myers Squibb position peaked at $13.2M in Q2 2023.
- 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.